Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Concin

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|September 2, 2018
The genetic landscape of 87 ovarian germ cell tumorsEls Van Nieuwenhuysen, Pieter Busschaert, Patrick Neven, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 10, 2021
Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysisJoanna Baum, Elena Ioana Braicu, Oliver Hunsicker, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2023
Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?Nicolò Bizzarri, Majdi Imterat, Robert Fruscio, et al.
Bulletin Du Cancer|March 26, 2023
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancerPhilipp Harter, Gerhard Bogner, Luis Chiva, et al.
The Lancet. Oncology|February 13, 2019
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trialJohann S de Bono, Nicole Concin, David S Hong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 24, 2024
Highlights from the 25th European Congress on Gynaecological Oncology in Barcelona: the ENYGO-IJGC Fellow InterviewsMartina Aida Angeles, Nuria Agusti, Giulio Bonaldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 ConsortiumNicole Concin, Ioana Braicu, Pierre Combe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical CancerDavid S Hong, Nicole Concin, Ignace Vergote, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 13, 2021
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinomaNicole Concin, Xavier Matias-Guiu, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 5, 2021
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinomaNicole Concin, Xavier Matias-Guiu, Ignace Vergote, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|September 2, 2018
The genetic landscape of 87 ovarian germ cell tumorsEls Van Nieuwenhuysen, Pieter Busschaert, Patrick Neven, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 10, 2021
Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysisJoanna Baum, Elena Ioana Braicu, Oliver Hunsicker, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2023
Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?Nicolò Bizzarri, Majdi Imterat, Robert Fruscio, et al.
Bulletin Du Cancer|March 26, 2023
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancerPhilipp Harter, Gerhard Bogner, Luis Chiva, et al.
The Lancet. Oncology|February 13, 2019
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trialJohann S de Bono, Nicole Concin, David S Hong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 24, 2024
Highlights from the 25th European Congress on Gynaecological Oncology in Barcelona: the ENYGO-IJGC Fellow InterviewsMartina Aida Angeles, Nuria Agusti, Giulio Bonaldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 ConsortiumNicole Concin, Ioana Braicu, Pierre Combe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical CancerDavid S Hong, Nicole Concin, Ignace Vergote, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 13, 2021
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinomaNicole Concin, Xavier Matias-Guiu, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 5, 2021
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinomaNicole Concin, Xavier Matias-Guiu, Ignace Vergote, et al.
Pageof 14